Pain Gene: Polyamine Signaling and Perception

Summary of the Study: SLC45A4 as a Pain Gene

This article details a recent study published in Nature identifying SLC45A4 as a key pain gene that encodes a neuronal polyamine transporter. Here’s a breakdown of the key findings:

Chronic Pain & Polyamines: Chronic pain affects a large portion of the population, and current treatments are frequently enough insufficient. Polyamines (spermidine, spermine, putrescine) are metabolites linked to chronic pain, influencing cell signaling and growth. Genome-Wide association Study (GWAS): Researchers performed a GWAS using data from the UK Biobank and replicated findings in the MVP and finngen cohorts.They identified several genetic variants associated with pain intensity, notably rs10625280 within the SLC45A4 gene.A missense variant, rs3739238, was also linked to pain, osteoarthritis, and immune dysfunction.
SLC45A4 Function: Previously thought to be a sucrose transporter, the study reveals SLC45A4 is actually a broad-specificity polyamine transporter. It utilizes a unique “plug domain” to regulate polyamine recognition and transport.
Substrate Identification: Correlation analysis showed SLC45A4 expression is linked to GABA levels. Experiments demonstrated it transports polyamines like putrescine and cadaverine,with the strongest affinity for putrescine and cadaverine.
Neural Expression: Slc45a4* (the mouse equivalent) is highly expressed in dorsal root ganglia (DRG) sensory neurons, suggesting a direct role in pain signaling.

In essence, the study identifies SLC45A4 as a crucial player in pain pathways by transporting polyamines, potentially offering a new target for pain treatment progress.